MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma

por Xu, Fei, Liao, Jia‐Zhi, Xiang, Guang‐Ya, Zhao, Peng‐Xuan, Ye, Feng, Zhao, Qiu, He, Xing‐Xing
Publicado 2017

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma

por Fan, Yin-Ping, Liao, Jia-Zhi, Lu, Ya-Qi, Tian, De-An, Ye, Feng, Zhao, Peng-Xuan, Xiang, Guang-Ya, Tang, Wang-Xian, He, Xing-Xing
Publicado 2017